Kirke Weaver - 31 Mar 2025 Form 4 Insider Report for Organon & Co. (OGN)

Reporting relationship: Gen. Counsel & Corp. Secy.
Issuer ticker: OGN
Reported as of: 31 Mar 2025
Net transaction value: -$88,395
SEC form: 4
Accepted by SEC: 02 Apr 2025, 17:39:47 UTC
Prior SEC filing: 07 May 2024
Next SEC filing: 07 May 2025
Source filing: View source filing
Reporting owner signature: /s/ Tarnetta V. Jones, as Attorney-in-Fact for Kirke Weaver

Key filing fact

Kirke Weaver filed Form 4 for Organon & Co. (OGN) on 02 Apr 2025.

Key facts

This page summarizes Kirke Weaver's Form 4 filing for Organon & Co. (OGN).
14 reported transactions and 6 derivative rows are listed below.
Accepted by SEC: 02 Apr 2025, 17:39.

Change

Previous filing in this sequence was filed on 07 May 2024.
Current net transaction value: -$88,395.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OGN transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +7,757
Change %: +27%
Price: $0.000000
Shares after: 36,917
Date: 31 Mar 2025
Ownership: Direct

OGN transaction

Common Stock

Tax liability

Transaction value: $32,067
Shares: -2,210
Change %: -6%
Price: $14.51
Shares after: 34,707
Date: 31 Mar 2025
Ownership: Direct
Footnotes: F1

OGN transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +6,200
Change %: +18%
Price: $0.000000
Shares after: 40,907
Date: 31 Mar 2025
Ownership: Direct

OGN transaction

Common Stock

Tax liability

Transaction value: $25,639
Shares: -1,767
Change %: -4.3%
Price: $14.51
Shares after: 39,140
Date: 31 Mar 2025
Ownership: Direct
Footnotes: F1

OGN transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +3,125
Change %: +8%
Price: $0.000000
Shares after: 42,265
Date: 31 Mar 2025
Ownership: Direct

OGN transaction

Common Stock

Tax liability

Transaction value: $12,928
Shares: -891
Change %: -2.1%
Price: $14.51
Shares after: 41,374
Date: 31 Mar 2025
Ownership: Direct
Footnotes: F1

OGN transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +4,294
Change %: +10%
Price: $0.000000
Shares after: 45,668
Date: 31 Mar 2025
Ownership: Direct

OGN transaction

Common Stock

Tax liability

Transaction value: $17,760
Shares: -1,224
Change %: -2.7%
Price: $14.51
Shares after: 44,444
Date: 31 Mar 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OGN transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +181,518
Change %
Price: $0.000000
Shares after: 181,518
Date: 31 Mar 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 181,518
Exercise price: $14.89
Footnotes: F2

OGN transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +36,937
Change %
Price: $0.000000
Shares after: 36,937
Date: 31 Mar 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 36,937
Exercise price
Footnotes: F3, F4

OGN transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -7,757
Change %: -33%
Price: $0.000000
Shares after: 15,514
Date: 31 Mar 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,757
Exercise price
Footnotes: F3, F5

OGN transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -6,200
Change %: -50%
Price: $0.000000
Shares after: 6,200
Date: 31 Mar 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 6,200
Exercise price
Footnotes: F3, F6

OGN transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -3,125
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 31 Mar 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,125
Exercise price
Footnotes: F3, F7

OGN transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -4,294
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 31 Mar 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4,294
Exercise price
Footnotes: F3, F8

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 8 footnotes

Footnote F1

This price is the closing market price of Organon & Co. ("Organon") common stock on Friday, March 28, 2025, as required by the plan under which the Restricted Stock Units ("RSU") were awarded.

Footnote F2

The Reporting Person was granted stock options, which vest and become exercisable in three equal installments on March 31, 2026, March 31, 2027, and March 31, 2028.

Footnote F3

Each RSU converts into one share of Organon common stock.

Footnote F4

The Reporting Person was granted RSUs, which represent a contingent right to receive one share of Organon common stock for each RSU. On March 31, 2025, RSUs were granted and will vest in three equal installments on each of March 31, 2026, March 31, 2027, and March 31, 2028.

Footnote F5

On March 29, 2024, RSUs were granted and on March 29, 2025, one-third of these RSUs vested, with the remaining RSUs to vest on March 29, 2026, and March 29, 2027. Since the first anniversary of the date of grant was on Saturday, March 29, 2025, the vesting occurred on Monday, March 31, 2025, the next business day.

Footnote F6

On March 31, 2023, RSUs were awarded and on March 31, 2025, one-third of these RSUs vested with the remaining RSUs to vest on March 31, 2026.

Footnote F7

On November 7, 2022, RSUs were awarded and on March 31, 2025, the final third of these RSUs vested.

Footnote F8

On March 31, 2022, RSUs were awarded and on March 31, 2025, the final third of these RSUs vested.